國立高雄大學圖資館 |

Language: English

Back

RNA activation

Li, Long-Cheng.

RNA activation

Record Type:	Electronic resources : Monograph/item
Title/Author:	RNA activationedited by Long-Cheng Li.
other author:	Li, Long-Cheng.
Published:	Singapore :Springer Singapore :2017.
Description:	xiv, 239 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	RNA.
Online resource:	http://dx.doi.org/10.1007/978-981-10-4310-9
ISBN:	9789811043109$q(electronic bk.)

RNA activation
RNA activation[electronic resource] /edited by Long-Cheng Li. - Singapore :Springer Singapore :2017. - xiv, 239 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.9830065-2598 ;. - Advances in experimental medicine and biology ;946..

PART I Exogenous RNAa -- PART II Endogenous RNAa -- PART III RNA activation guided by other small RNAs -- PART IV Developing RNAa-based therapeutics.

This book offers an essential guide to RNA activation (RNAa), an emerging and fascinating new field. RNAa is a small RNA-guided and Argonaute-dependent gene regulation phenomenon in which promoter-targeted short double-stranded RNAs (dsRNAs) induce target gene expression at the transcriptional level. It occurs primarily in the nucleus and can be mediated by artificially designed short duplex RNAs that target regulatory sequences (e.g., promoters, genes' 3' termini and enhancers) and naturally occurring small RNAs (e.g., miRNAs and C. elegans 22G-RNAs) With contributions from internationally respected RNA experts, this book provides comprehensive coverage of different RNAa mechanisms and a timely update on recent advances in RNAa research, with a focus on developing RNAa-based therapeutics. Special chapters are also devoted to the topics of gene activation induced by antisense oligonucleotides and the CRISPR system. As the first book to cover RNAa, it will be of interest to a wide audience, from scientists in academia and the pharmaceutical industry to clinicians who wish to further explore the biology of RNAa and related phenomena, so as to harness their full potential for use in biotechnology and drug development.

ISBN: 9789811043109$q(electronic bk.)

Standard No.: 10.1007/978-981-10-4310-9doiSubjects--Topical Terms:

216963
RNA.

LC Class. No.: QP623

Dewey Class. No.: 572.88

RNA activation
LDR:02405nmm a2200337 a 4500 001 517545
003 DE-He213
005 20170621060025.0
006 m d
007 cr nn 008maaau
008 180316s2017 si s 0 eng d
020 $a 9789811043109$q(electronic bk.)
020 $a 9789811043093$q(paper)
024 7 $a 10.1007/978-981-10-4310-9 $2 doi
035 $a 978-981-10-4310-9
040 $a GP $c GP
041 0 $a eng
050 4 $a QP623
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
072 7 $a SCI029000 $2 bisacsh
082 0 4 $a 572.88 $2 23
090 $a QP623 $b .R627 2017
245 0 0 $a RNA activation $h [electronic resource] / $c edited by Long-Cheng Li.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2017.
300 $a xiv, 239 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.983
505 0 $a PART I Exogenous RNAa -- PART II Endogenous RNAa -- PART III RNA activation guided by other small RNAs -- PART IV Developing RNAa-based therapeutics.
520 $a This book offers an essential guide to RNA activation (RNAa), an emerging and fascinating new field. RNAa is a small RNA-guided and Argonaute-dependent gene regulation phenomenon in which promoter-targeted short double-stranded RNAs (dsRNAs) induce target gene expression at the transcriptional level. It occurs primarily in the nucleus and can be mediated by artificially designed short duplex RNAs that target regulatory sequences (e.g., promoters, genes' 3' termini and enhancers) and naturally occurring small RNAs (e.g., miRNAs and C. elegans 22G-RNAs) With contributions from internationally respected RNA experts, this book provides comprehensive coverage of different RNAa mechanisms and a timely update on recent advances in RNAa research, with a focus on developing RNAa-based therapeutics. Special chapters are also devoted to the topics of gene activation induced by antisense oligonucleotides and the CRISPR system. As the first book to cover RNAa, it will be of interest to a wide audience, from scientists in academia and the pharmaceutical industry to clinicians who wish to further explore the biology of RNAa and related phenomena, so as to harness their full potential for use in biotechnology and drug development.
650 0 $a RNA. $3 216963
650 0 $a Gene expression. $3 188888
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Gene Expression. $3 220379
650 2 4 $a Biochemistry, general. $3 273649
650 2 4 $a Cell Biology. $3 274165
650 2 4 $a Molecular Medicine. $3 273932
650 2 4 $a Cancer Research. $3 273660
700 1 $a Li, Long-Cheng. $3 787190
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-4310-9
950 $a Biomedical and Life Sciences (Springer-11642)